Загрузка...

Preventive effects of the sodium glucose cotransporter 2 inhibitor tofogliflozin on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic mice

Sodium glucose cotransporter 2 inhibitors are expected to ameliorate the abnormalities associated with metabolic syndrome including non-alcoholic fatty liver disease. In this study, we investigated the effects of the sodium glucose cotransporter 2 inhibitor tofogliflozin on the development of non-al...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncotarget
Главные авторы: Obara, Koki, Shirakami, Yohei, Maruta, Akinori, Ideta, Takayasu, Miyazaki, Tsuneyuki, Kochi, Takahiro, Sakai, Hiroyasu, Tanaka, Takuji, Seishima, Mitsuru, Shimizu, Masahito
Формат: Artigo
Язык:Inglês
Опубликовано: Impact Journals LLC 2017
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5601657/
https://ncbi.nlm.nih.gov/pubmed/28938561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16874
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!